LOGIN  |  REGISTER

Recent Insider Transactions - CAMP4 Therapeutics (NASDAQ: CAMP)

Follow NASDAQ:CAMP Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CAMP CAMP4 Therapeutics
Tardiff Daniel / officer: Chief Scientific Officer
10/01/2025
Sell
$9.08
22,289
$202K
0
NASDAQ CAMP CAMP4 Therapeutics
Tardiff Daniel / officer: Chief Scientific Officer
10/01/2025
Sell
$3.86
25,000
$97K
0
NASDAQ CAMP CAMP4 Therapeutics
Tardiff Daniel / officer: Chief Scientific Officer
10/01/2025
Sell
$3.53
5,000
$18K
0
NASDAQ CAMP CAMP4 Therapeutics
Schwab Andrew J. / director, 10 percent owner:
09/11/2025
Buy
$1.53
2.94M
$4.500M
2.94M
NASDAQ CAMP CAMP4 Therapeutics
5AM Partners VI, LLC / 10 percent owner
09/11/2025
Buy
$1.53
2.94M
$4.500M
2.94M
NASDAQ CAMP CAMP4 Therapeutics
Polaris Management Co. VII, L.L.C. / 10 percent owner
09/11/2025
Buy
$1.53
1.22M
$1.869M
2.83M
NASDAQ CAMP CAMP4 Therapeutics
Polaris Management Co. VII, L.L.C. / 10 percent owner
09/11/2025
Buy
$1.53
85,468
$131K
197,661
NASDAQ CAMP CAMP4 Therapeutics
Nashat Amir / director, 10 percent owner:
09/11/2025
Buy
$1.53
1.22M
$1.869M
2.83M
NASDAQ CAMP CAMP4 Therapeutics
Nashat Amir / director, 10 percent owner:
09/11/2025
Buy
$1.53
85,468
$131K
197,661
NASDAQ CAMP CAMP4 Therapeutics
Maricich Yuri / officer: Chief Medical Officer
09/11/2025
Buy
$1.65
6,060
$10K
6,060
NASDAQ CAMP CAMP4 Therapeutics
Gold Kelly / officer: Chief Financial Officer
09/11/2025
Buy
$1.65
6,060
$10K
67,877
NASDAQ CAMP CAMP4 Therapeutics
Mandel-Brehm Josh / director, officer: Chief Executive Officer
09/11/2025
Buy
$1.65
6,060
$10K
278,417
NASDAQ CAMP CAMP4 Therapeutics
Young Richard A / director
09/11/2025
Buy
$1.65
15,151
$25K
170,010

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous